Low‐Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor. (1st July 2015)

• Record Type: Journal Article
• Authors: Brand, Caroline; Dencks, Stefanie; Schmitz, Georg; Mühlmeister, Mareike; Stypmann, Jörg; Ross, Rebecca; Hintelmann, Heike; Schliemann, Christoph; Müller-Tidow, Carsten; Mesters, Rolf M.; Berdel, Wolfgang E.; Schwöppe, Christian
• Is Part Of: Journal of ultrasound in medicine. Volume 34:Number 7(2015)
• Page Start: 1227
• Page End: 1236
• Publication Date: 2015-07-01
• Subjects: low-energy ultrasound treatment -- regional cancer therapy -- truncated tissue factor -- vascular infarction -- vascular targeting -- vascular ultrasound; Ultrasonics in medicine -- Periodicals; Ultrasonics; Ultrasonography; Ultrasonics in medicine; Electronic journals; Periodicals; Periodicals; 616.07543
• DOI: 10.7863/ultra.34.7.1227
• Languages: English
• ISSNs: 0278-4297

Abstract

Abstract : Objectives: To enhance the regional antitumor activity of the vascular‐targeting agent truncated tissue factor (tTF)‐NGR by combining the therapy with low‐energy ultrasound (US) treatment. Methods: For the in vitro US exposure of human umbilical vein endothelial cells (HUVECs), cells were put in the focus of a US transducer. For analysis of the US‐induced phosphatidylserine (PS) surface concentration on HUVECs, flow cytometry was used. To demonstrate the differences in the procoagulatory efficacy of TF‐derivative tTF‐NGR on binding to HUVECs with a low versus high surface concentration of PS, we performed factor X activation assays. For low‐energy US pretreatment, HT1080 fibrosarcoma xenotransplant‐bearing nude mice were treated by tumor‐regional US‐mediated stimulation (ie, destruction) of microbubbles. The therapy cohorts received the tumor vessel‐infarcting tTF‐NGR protein with or without US pretreatment (5 minutes after US stimulation via intraperitoneal injection on 3 consecutive days). Results: Combination therapy experiments with xenotransplant‐bearing nude mice significantly increased the antitumor activity of tTF‐NGR by regional low‐energy US destruction of vascular microbubbles in tumor vessels shortly before application of tTF‐NGR ( P < .05). Mechanistic studies proved the upregulation of anionic PS on the outer leaflet of the lipid bilayer of endothelial cell membranes by low‐energy US and a consecutive higher potential of these preapoptotic endothelial cells to activate coagulation via tTF‐NGR and coagulation factor X as being a basis for this synergistic activity. Conclusions: Combining retargeted tTF to tumor vessels with proapoptotic stimuli for the tumor vascular endothelium increases the antitumor effects of tumor vascular infarction. Ultrasound treatment may thus be useful in this respect for regional tumor therapy.